Get the app!
Back to Trades

Kazam Joshua A

DirectorCIK 0001221355

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
2
Buy transactions
0
Sell transactions
0
Companies
1
Active
2025–2026

Across 2 filings between 2025–2026, Kazam Joshua A, Director, has disclosed $0 in transactions — all concentrated in Allogene Therapeutics, Inc. (ALLO). Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

2 loaded
Jun 23ALLO
Allogene Therapeutics, Inc.
Kazam Joshua ADirectorExercise$0
Dec 22ALLO
Allogene Therapeutics, Inc.
Kazam Joshua ADirectorExercise$0

2 filings